Tandem Diabetes Care (TNDM) Competitors $14.81 -0.15 (-1.00%) As of 01:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. TMDX, SLNO, NVST, LIVN, INSP, WRBY, LQDA, EYE, AORT, and LMATShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Inspire Medical Systems (INSP), Warby Parker (WRBY), Liquidia Technologies (LQDA), National Vision (EYE), Artivion (AORT), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Its Competitors TransMedics Group Soleno Therapeutics Envista LivaNova Inspire Medical Systems Warby Parker Liquidia Technologies National Vision Artivion LeMaitre Vascular TransMedics Group (NASDAQ:TMDX) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation. Do analysts rate TMDX or TNDM? TransMedics Group presently has a consensus target price of $130.73, indicating a potential upside of 2.51%. Tandem Diabetes Care has a consensus target price of $21.19, indicating a potential upside of 43.06%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62Tandem Diabetes Care 1 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.18 Which has more risk & volatility, TMDX or TNDM? TransMedics Group has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Does the media favor TMDX or TNDM? In the previous week, Tandem Diabetes Care had 4 more articles in the media than TransMedics Group. MarketBeat recorded 15 mentions for Tandem Diabetes Care and 11 mentions for TransMedics Group. Tandem Diabetes Care's average media sentiment score of 0.91 beat TransMedics Group's score of 0.75 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, TMDX or TNDM? TransMedics Group has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.85$35.46M$1.9366.08Tandem Diabetes Care$940.20M1.06-$96.03M-$3.09-4.79 Is TMDX or TNDM more profitable? TransMedics Group has a net margin of 13.49% compared to Tandem Diabetes Care's net margin of -20.51%. TransMedics Group's return on equity of 28.02% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% Tandem Diabetes Care -20.51%-65.40%-13.87% Do institutionals and insiders have more ownership in TMDX or TNDM? 99.7% of TransMedics Group shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryTransMedics Group beats Tandem Diabetes Care on 12 of the 16 factors compared between the two stocks. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.00B$7.57B$6.16B$10.66BDividend YieldN/A1.14%5.72%4.86%P/E Ratio-4.7927.2629.5428.34Price / Sales1.0627.77577.73128.29Price / CashN/A22.2737.1261.42Price / Book3.695.2612.066.50Net Income-$96.03M$178.09M$3.32B$276.64M7 Day Performance-3.14%-0.66%-0.48%-0.11%1 Month Performance15.97%0.88%5.54%1.39%1 Year Performance-53.93%2.77%65.53%32.46% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.19 of 5 stars$14.81-1.0%$21.19+43.1%-55.4%$1.00B$940.20M-4.792,650Analyst ForecastTMDXTransMedics Group2.6358 of 5 stars$119.90+1.9%$127.18+6.1%-2.8%$4.09B$441.54M62.12210News CoverageUpcoming EarningsAnalyst UpgradeGap UpSLNOSoleno Therapeutics4.2856 of 5 stars$65.450.0%$115.92+77.1%+24.7%$3.48BN/A-15.8130NVSTEnvista3.7028 of 5 stars$20.14+0.9%$21.08+4.7%+6.4%$3.35B$2.51B62.9412,300News CoverageUpcoming EarningsLIVNLivaNova2.8853 of 5 stars$54.10+0.7%$59.71+10.4%+2.9%$2.95B$1.25B-13.912,900News CoveragePositive NewsINSPInspire Medical Systems4.8232 of 5 stars$80.91+3.7%$148.00+82.9%-58.7%$2.39B$802.80M46.771,246Positive NewsWRBYWarby Parker2.2974 of 5 stars$21.77+0.3%$24.75+13.7%+22.6%$2.29B$821.35M-310.973,780LQDALiquidia Technologies3.6029 of 5 stars$24.44+8.7%$32.38+32.5%+99.5%$2.10B$14M-14.3850Analyst ForecastEYENational Vision2.6595 of 5 stars$25.49-1.2%$24.73-3.0%+165.5%$2.02B$1.82B-141.6113,411Positive NewsAORTArtivion2.731 of 5 stars$42.53+1.1%$43.97+3.4%+63.7%$2.01B$405.04M-101.271,600LMATLeMaitre Vascular3.3772 of 5 stars$88.01+1.6%$97.60+10.9%+3.2%$1.99B$219.86M42.72490 Related Companies and Tools Related Companies TMDX Alternatives SLNO Alternatives NVST Alternatives LIVN Alternatives INSP Alternatives WRBY Alternatives LQDA Alternatives EYE Alternatives AORT Alternatives LMAT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNDM Stock Alerts